#Total Knee Arthroplasty Market

[david843346]

Cementless Total Knee Arthroplasty Market: Global Demand Analysis & Opportunity Outlook 2036

Research Nester’s recent market research analysis on “Cementless Total Knee Arthroplasty Market: Global Demand Analysis & Opportunity Outlook 2036” delivers a detailed competitors analysis and a detailed overview of the global cementless total knee arthroplasty market in terms of market segmentation by type, end user, and by region.

Preference for Cementless TKA by Surgeons and Patients to Promote Global Market Share of Cementless Total Knee Arthroplasty

Cementless TKA has gained popularity due to its potential benefits, such as reduced risk of implant loosening and infection. Many orthopedic surgeons and patients prefer cementless TKA as it provides a more bone-conserving option compared to cemented TKA. Research published in the Journal of Bone and Joint Surgery (JBJS) reveals that cementless TKA is associated with a lower revision rate compared to cemented TKA. Patients and surgeons are increasingly choosing this option to achieve better long-term results.

Some of the major growth factors and challenges that are associated with the growth of the global cementless total knee arthroplasty market are:

Growth Drivers:

•        Increasing Prevalence of Osteoarthritis

•        Growing Regulatory Environment and Quality Assurance

Challenges:

In many regions, access to specialized orthopedic care, including TKA procedures, may be limited, particularly in rural areas. Patients in underserved areas may face difficulties in getting timely and appropriate treatment. This lack of access can delay necessary surgeries. High-quality cementless TKA implants can be expensive. The cost of these implants may pose a financial barrier for healthcare providers and patients, especially in regions with limited healthcare resources. Cost-effective solutions and pricing strategies are needed to ensure wider accessibility.

Request Report Sample@

The primary cementless TKA segment is to garner a highest revenue by the end of 2036 by growing at a significant CAGR over the forecast period. Obesity is significant growth driver for primary cementless TKA procedures within the global market. Obesity is a well-established risk factor for osteoarthritis and knee joint problems. With rising obesity rates in many parts of the world, an increasing number of individuals are at risk of developing osteoarthritis and may ultimately require primary cementless TKA to address the joint damage resulting from excessive weight. The World Health Organization (WHO) reports that obesity rates have been steadily increasing worldwide, with obesity now considered a global epidemic. Obesity-related osteoarthritis is a leading cause of disability, underscoring the necessity for joint replacement procedures, including primary cementless TKA.

By region, the Europe cementless total knee arthroplasty market is to generate a notable revenue by the end of 2036. Europe has a steadily aging population, with a significant percentage of individuals over the age of 65. As people age, the risk of developing knee-related conditions, such as osteoarthritis, increases. This demographic shift drives the demand for joint replacement procedures, including cementless TKA. Osteoarthritis is a leading indication for TKA, and its prevalence is on the rise in Europe. Factors such as lifestyle changes and obesity contribute to the increasing incidence of knee joint problems, necessitating joint replacement surgeries. Europe is a hub for medical technology innovation. Continuous advancements in implant design, materials, and surgical techniques have significantly improved the success and longevity of cementless TKA procedures. These innovations enhance patient outcomes and surgeon efficiency.

Access our detailed report at:

[farmacuticals]

Technological Advances Shaping the Future of Cementless Knee Replacement Solutions

The cementless total knee arthroplasty (TKA) market has witnessed significant growth in recent years due to advancements in orthopedic technologies and an increasing aging population. Unlike traditional knee replacements that use cement to secure implants, cementless TKA uses a press-fit technique where the bone is encouraged to grow into the implant. This approach often leads to greater longevity and improved outcomes, especially for younger, more active patients. The cementless total knee arthroplasty market overview reveals a growing preference for these devices, as they offer increased durability, reduced infection risk, and lower complication rates. As a result, there is rising demand from both patients and healthcare providers.

According to MRFR analysis, the market size for cementless total knee replacement was projected to reach 2.35 billion USD in 2022. The market for cementless total knee replacement is anticipated to increase from 2.53 billion US dollars in 2023 to 4.8 billion US dollars in 2032. The market for cementless total knee replacement is anticipated to expand at a pace of about 7.39% between 2024 and 2032.

Cementless Total Knee Arthroplasty Market Size

The cementless total knee arthroplasty market size is expected to expand significantly, driven by advancements in implant design, material science, and surgical techniques. The global market size was valued at several billion dollars in recent years and is projected to grow at a compound annual growth rate (CAGR) of over 5% from 2023 to 2030. This increase is attributed to the growing prevalence of osteoarthritis and rheumatoid arthritis, which are leading causes of knee pain and disability. As awareness and access to advanced healthcare solutions increase worldwide, the cementless total knee arthroplasty market size will likely see substantial expansion across North America, Europe, and Asia-Pacific, particularly in regions with a high elderly population.

Cementless Total Knee Arthroplasty Market Share

Cementless knee replacements currently hold a significant share of the orthopedic implants market, especially among younger patients and in developed countries. With the increasing preference for long-lasting and biologically compatible implants, the cementless total knee arthroplasty market share is expected to continue growing. Major players in the market include Zimmer Biomet, Stryker, and Smith & Nephew, each striving to capture a larger portion of the market through innovations, collaborations, and strategic expansions. These companies have been developing new materials and designs that promote bone integration and stability. In addition, the entry of new market players and partnerships with healthcare providers has contributed to a more competitive landscape, driving further growth in market share.

Cementless Total Knee Arthroplasty Market Analysis

A detailed cementless total knee arthroplasty market analysis highlights several factors driving this market’s growth. Factors such as the rising incidence of osteoarthritis, improvements in surgical techniques, and increased awareness of cementless knee implants are major growth drivers. Moreover, with a shift towards minimally invasive surgeries and outpatient procedures, cementless TKA options are becoming more accessible and appealing. Additionally, the advancements in 3D printing and personalized implant designs have further optimized implant fit and functionality, enhancing patient satisfaction and outcomes. A thorough cementless total knee arthroplasty market analysis also points to increasing R&D investments as companies look to improve implant performance and reduce revision rates.

Cementless Total Knee Arthroplasty Market Trends

Several cementless total knee arthroplasty market trends are shaping the industry, including the adoption of robotic-assisted surgeries, which allow for greater precision in implant placement, reducing wear and improving outcomes. Personalized implants tailored to an individual’s anatomy through 3D printing technology are also gaining popularity, as they enhance implant fit and longevity. Furthermore, advanced materials like titanium and porous metals are becoming more common, as they promote bone ingrowth and provide a more stable interface. Another emerging trend is the focus on outpatient procedures, as more healthcare providers shift to cost-effective, minimally invasive techniques. These trends indicate a strong growth trajectory for the cementless TKA market in the coming years.

Reasons to Buy the Cementless Total Knee Arthroplasty Market Report

Comprehensive market insights, including market size, growth projections, and competitive landscape analysis.

Detailed segmentation data by product type, material, region, and end-user, aiding strategic planning.

Information on recent technological advancements and innovations in cementless TKA implants.

Insights into market trends and emerging opportunities for key players and new entrants.

Evaluation of regional dynamics to understand growth potential in key markets.

Recent Developments in the Cementless Total Knee Arthroplasty Market

Recent developments in the cementless total knee arthroplasty market include the introduction of new materials that promote bone growth, such as titanium and hydroxyapatite-coated implants. Major companies like Zimmer Biomet and Stryker have also launched new cementless knee systems optimized for robotic-assisted surgeries, improving precision and reducing complications. Additionally, advancements in 3D printing allow for customized implants that better match patient anatomy, leading to better post-surgical outcomes and higher satisfaction rates. Partnerships and acquisitions are further strengthening the market, as companies collaborate with research institutions to innovate and bring next-generation implants to market faster.

Related reports:

automated endoscopy reprocessor market

bacteriological testing market

biliary stents market

Top of Form

Bottom of Form

[industrynewsupdates]

Bioresorbable Polymers Market Growth: Key Drivers and Trends to Watch

The global bioresorbable polymers market was valued at USD 1.30 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 13.8% from 2023 to 2030. The market expansion is primarily driven by a combination of factors, including the rising consumer health awareness, improvements in healthcare facilities, and an increasing number of surgical procedures performed worldwide. According to data from the National Library of Medicine (NLM), around 310 million major surgeries are conducted globally each year, with 20 million surgeries taking place in Europe and 40 to 50 million in the United States. Bioresorbable polymers are a class of materials that can be naturally broken down and absorbed by the body over time, making them highly suitable for medical applications.

These polymers are produced by polymerizing bio-based raw materials through specialized industrial processes. The increasing demand for medical implants, such as cochlear implants, pacemakers, breast implants, and hip implants, is another significant factor driving the growth of the bioresorbable polymers market. As reported by the National Institute on Deafness and Other Communication Disorders (NIDCD), over 737,000 cochlear implants were implanted globally by December 2019. Similarly, the Organization for Economic Cooperation and Development (OECD) noted that hip replacement surgeries increased by 22% between 2009 and 2019, and knee replacements saw an increase of 35% in the same period. This growing need for medical implants is further boosting the market demand for bioresorbable polymers.

Gather more insights about the market drivers, restrains and growth of the Bioresorbable Polymers Market

Application Insights

In 2022, the orthopedics segment emerged as the leading application for bioresorbable polymers, accounting for 43.6% of the total market revenue. This dominance is largely driven by the increasing prevalence of orthopedic conditions such as arthritis, osteoporosis, and degenerative joint diseases, which are exacerbated by factors like an aging population, sedentary lifestyles, obesity, and a lack of physical activity. The rising demand for orthopedic procedures, including knee and hip replacements, is expected to continue fueling growth in this segment.

For example, the National Institutes of Health (NIH) reported that total knee arthroplasty (TKA) was the most commonly performed inpatient surgical procedure in the U.S., with over 1.37 million procedures performed in 2020. The number of TKA surgeries is expected to rise significantly, reaching 3.48 million annually by 2030. Medical products such as screws, sutures, stents, and pins made from bioresorbable polymers are increasingly being used in a variety of medical procedures, including joint repairs and prosthetics. Companies like Evonik Industries AG are developing and offering a range of bioresorbable medical products, such as surgical screws, which are designed to enhance patient care by improving clinical outcomes and reducing the need for additional surgeries. These resorbable implants also help to lower healthcare costs by eliminating the need for secondary removal procedures, a key benefit that is driving their adoption.

Another promising application area for bioresorbable polymers is drug delivery, which is projected to experience the fastest growth during the forecast period, with a CAGR of 15.7%. This growth is largely attributed to the rising prevalence of chronic diseases and the expanding aging population, both of which create a growing demand for more efficient drug delivery systems. Bioresorbable polymers are especially beneficial in drug delivery because they reduce the need for invasive procedures. For instance, implantable devices or sustained-release formulations can help minimize the frequency of invasive procedures, leading to improved patient comfort, reduced healthcare costs, and better therapeutic outcomes.

A notable development in this area occurred in June 2020, when Evonik launched the RESOMER Precise platform, a breakthrough innovation in custom functional polymeric excipients. This platform allows pharmaceutical companies to have unprecedented control over the release profile of parenteral drug products, which is crucial for ensuring consistent and effective treatment. The RESOMER platform, developed using Evonik’s advanced process technology, not only improves the stability of drug products but also helps to mitigate regulatory risks associated with complex drug formulations. This innovation is expected to contribute significantly to the growth of bioresorbable polymers in drug delivery applications, offering enhanced precision and effectiveness in treating a variety of medical conditions.

Order a free sample PDF of the Bioresorbable Polymers Market Intelligence Study, published by Grand View Research.

[market-insider]

Continuous Peripheral Nerve Block Catheters Products: Understanding Market Size, Share, and Growth Trajectories

The global continuous peripheral nerve block (cPNB) catheters market is expected to reach USD 292.8 million by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 6.2% during the forecast period. Growing orthopedic surgery volumes resulting from the rising prevalence of osteoarthritis and increasing preference for ambulatory surgical centers are the key growth stimulants for the cPNB catheters market. According to the Healthcare Cost and Utilization Project (HCUP), over 546,000 total hip arthroplasty and 789,500 total knee arthroplasty procedures were performed in the U.S. in 2014. Of these, almost 70.0% of hip replacement operations are performed to relieve symptoms of osteoarthritis. This shows the potential demand for these devices in the coming years.

Further key findings from the study suggest

The ultrasound segment, based on the insertion technique, held the dominant share of 48.2% owing to associated advantages including improved block quality, faster and longer block duration, and a reduced dose of local anesthetic

Lower extremity surgeries represented the most prominent position in the market due to the increasing number of hip and knee replacement surgeries involving the use of cPNB catheters

The ambulatory surgical centers segment is estimated to exhibit a noteworthy CAGR during the forecast period. This can be attributed to related benefits such as shorter waiting list, quick discharge, reduced overall procedural cost, and treatment of a higher number of patients

Hospitals held 58.5% of the cPNB catheters market

Europe is anticipated to register a CAGR of 6.4% during the forecast period owing to the high number of surgeries performed in this region, which involve cPNB usage to manage postoperative pain.

For More Details or Sample Copy please visit link @: cPNB Catheters Market Report

The rate of ambulatory surgeries is escalating due to a growing number of ambulatory surgical centers (ASCs), shortened recovery time, and continued improvements in regional anesthesia techniques. Costs of surgeries in ASC settings are approximately 60.0% less in comparison to those performed in hospitals. The recent inclusion of ambulatory surgeries for reimbursement of knee replacement surgeries by the Centers for Medicare & Medicaid Services in the U.S., along with the inherent benefits of cPNB usage, is likely to boost the demand for these catheters in the coming years.

On the competitive front, the leading players in this space are Pajunk GmbH and B. Braun Melsungen AG. Companies with wider distributor reach, larger product portfolio, and advanced technologies are seen to lead the space. Some other key players are Teleflex, Halyard, and Vygon, which are projected to have a stronger market presence by 2025. Less prominent players trailing behind include Ace Medical, Temena, Epimed International, and others.

Top Companies in the Continuous Peripheral Nerve Block Catheters Market

B. Braun Melsungen AG

Teleflex Incorporated

Halyard Health, Inc

Pajunk GmbH

Epimed International

Ace Medical

Vygon

[divyabodhwani23]

Pioneering Transplants: Analyzing Trends in the Osteochondral Allografts Market

The Osteochondral Allografts Market is a vital segment within the orthopedic industry, offering innovative solutions for the treatment of cartilage defects, osteochondral lesions, and joint injuries. Osteochondral allograft transplantation involves the surgical implantation of donated tissue, typically from cadaveric sources, to repair damaged cartilage and restore joint function. This market analysis explores the key drivers, trends, challenges, and opportunities shaping the Osteochondral Allografts Market.

𝐆𝐞𝐭 𝐟𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞: https://www.marketdigits.com/request/sample/4684

One of the primary drivers of the Osteochondral Allografts Market is the increasing prevalence of joint injuries and osteoarthritis, fueled by factors such as aging populations, sports-related injuries, and rising obesity rates. Cartilage defects and osteochondral lesions can lead to pain, stiffness, and impaired mobility, significantly impacting patients' quality of life. Osteochondral allograft transplantation offers a viable treatment option for patients with symptomatic joint defects who have failed conservative therapies, such as physical therapy and medication.

Moreover, advancements in surgical techniques, tissue processing methods, and preservation technologies have improved the safety, efficacy, and availability of osteochondral allografts for transplantation. Innovations in tissue banking, including cryopreservation, irradiation, and decellularization, ensure the biomechanical integrity and immunogenicity of allograft tissues while reducing the risk of disease transmission and graft rejection. These technological advancements have expanded the clinical applications of osteochondral allografts to a wide range of joints, including the knee, ankle, shoulder, and elbow.

Furthermore, the growing demand for minimally invasive surgical procedures and tissue-preserving techniques has driven interest in osteochondral allograft transplantation as a viable alternative to traditional joint replacement surgeries. Unlike total joint arthroplasty, which involves the removal of the entire joint surface, osteochondral allograft transplantation preserves the native joint anatomy and biomechanics, minimizing the risk of implant wear, loosening, and long-term complications. As patients and healthcare providers seek alternatives to joint replacement surgeries, osteochondral allograft transplantation offers a less invasive, joint-preserving option for cartilage restoration.

In addition to its applications in primary cartilage repair, osteochondral allograft transplantation plays a critical role in revision surgeries and salvage procedures for failed cartilage repair techniques, such as microfracture, autologous chondrocyte implantation (ACI), and osteochondral autograft transfer (OAT). Patients with recurrent or extensive cartilage damage may benefit from osteochondral allografts as a salvage option to address large defects, restore joint congruity, and delay or avoid joint replacement surgery. This expanding indication for osteochondral allograft transplantation contributes to market growth and adoption in orthopedic practice.

However, the Osteochondral Allografts Market also faces challenges and limitations that may impact its widespread adoption and commercialization. One of the main challenges is the availability and quality of donor tissue, as the supply of suitable allografts depends on factors such as donor screening, tissue processing, and storage protocols. Tissue banks must adhere to stringent regulatory standards and quality assurance measures to ensure the safety, efficacy, and traceability of allograft tissues for transplantation.

Moreover, cost considerations, reimbursement policies, and healthcare economics influence the adoption and utilization of osteochondral allografts in clinical practice. Osteochondral allograft transplantation can be a costly procedure, requiring specialized equipment, surgical expertise, and postoperative rehabilitation. Reimbursement policies vary by region and payer, affecting patient access to osteochondral allograft transplantation and the financial viability of healthcare providers offering these services.

In conclusion, the Osteochondral Allografts Market represents a promising frontier in orthopedic surgery, offering innovative solutions for cartilage restoration and joint preservation. By leveraging advancements in tissue engineering, surgical techniques, and preservation technologies, osteochondral allograft transplantation has the potential to improve patient outcomes, extend joint longevity, and enhance quality of life for individuals with joint injuries and osteoarthritis. While challenges remain, ongoing research, collaboration, and innovation in the field are driving progress and expanding the clinical applications of osteochondral allografts in orthopedic practice.

[bhushans]

Unveiling the Power of Data: Global Joint Replacement Market

A newly released Global Joint Replacement Market According to a Future Market Insights analysis report, the joint replacement market had global sales of US$ 17.1 billion in 2021. It is anticipated that the market would reach a valuation of US$ 27 billion by 2032, growing at a CAGR of 4.3% between 2022 and 2032. With a predicted CAGR of more than 4.1% from 2022 to 2032, knee replacement is anticipated to be the segment that generates the most income.

Joint reconstruction comes across as a remarkable part of global orthopedic devices vertical. The conditions adversely affecting joints are inclusive of all kinds of arthritis, bone degenerative diseases, osteoporosis, and the other injuries. It needs to be noted that these ailments no longer pertain to aging population. Sedentary lifestyles are responsible for these ailments.

Joint reconstruction encloses a broad spectrum of treatments like physiotherapy, surgeries, and pain management. The very first type of therapy preferred is that of ‘physiotherapy’. Though it caters to primary care, surgical procedures do prove to be permanent course of cure. Minimally invasive surgeries are preferred as they provide benefits like convenience factor for surgeons and patients alike, lesser timespan of hospital stay, and shorter ‘turnaround’ time. Artificial implants dominate the joint reconstruction devices market as they offer simple installation. Arthroscopes enable outpatient surgeries as well. Advanced tools include image magnifiers and pre-operative planning.

Get a Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-16281

Future Market Insights has walked through these facts with future perspectives in its latest market study entitled ‘Joint Reconstruction Devices Market’ through its dedicated team of analysts and consultants. The bottom-up approach is bound to go a long way regarding the rapport with clientele. Also, micros and macros have been efficiently worked upon.

Key Takeaways: •North America holds more than 30% of the market share. This could be credited to the US housing a huge number of industry players.

•Europe stands second on the similar grounds and the status quo is expected to remain unchanged even going forward.

•The Asia-Pacific is expected to grow at the fastest rate in the joint reconstruction devices market. This could be attributed to FDI being approved by the governments of India and China. Japan is another country leading from the front.

•With increase in the number of distribution partners, Mexico and Brazil are expected to dominate joint reconstruction devices market for LATAM.

Competitive Devices •Smith + Nephew, in February 2022, did announce launching next generation handheld robotics platform called ‘CORI Surgical System’ at the commercial scale. It stands out from its counterparts with respect to compactness. Minimal set-up time along with portability implies that it could be moved from one theater to the other for optimizing patients’ flow via surgical units.

•Zimmer Biomet Holdings, Inc., in December 2020, did announce that it had completed acquisition of A&E Medical Corporation and its entire portfolio comprising sternal closure devices. They included cable systems, sternal sutures, and rigid fixation.

•DePuy Synthes, in March 2022, did acquire CUPTIMIZE Hip-Spine Analysis – a tool floated with the objective of better understanding and addressing effect of abnormal motion between pelvis and spine in certain patients who need THA (total hip arthroplasty). It improvises on surgical planning capabilities related to VELYS Hip Navigation (a solution from DePuy Synthes’ VELYS Digital Surgery platform for connected technologies).

•LimaCorporate, in October 2022, did receive approval from the US FDA for a new-fangled shoulder platform emphasized on glenoid baseplate. Humeral stem is 3D-printed in its entirety. This dental implant system, using patented TT (Trabecular Titanium) technology, does aim to obtain robust primary fixation with successful growth of secondary bone.

•Smith + nephew PLC, in September 2022, did launch OR3O dual mobility system for usage in revision and primary arthroplasty in Japan. “With success with respect to rheumatoid arthritis and osteoarthritis, the global joint reconstruction devices market is bound to grow inadvertently in the near future”, says an analyst from Future Market Insights.

How does the Report reconstruct itself? •The research study is based on technology (joint reconstruction devices for joint replacement, joint reconstruction devices for osteotomy, joint reconstruction devices for arthroscopy, joint reconstruction devices for resurfacing, joint reconstruction devices for arthrodesis, and joint reconstruction devices for other technologies), and by type (knee joint reconstruction devices, hip joint reconstruction devices, shoulder joint reconstruction devices, ankle joint reconstruction devices, and other joint reconstruction devices).

•With growing occurrences of orthopedic diseases coupled with increasing geriatric population, the global joint reconstruction devices market is expected to witness a noteworthy CAGR in the near future.

Key Segments Covered In The Joint Reconstruction Devices Industry Survey Joint Reconstruction Devices Market by Technology: •Joint Reconstruction Devices for Joint Replacement •Joint Reconstruction Devices for Osteotomy •Joint Reconstruction Devices for Arthroscopy •Joint Reconstruction Devices for Resurfacing •Joint Reconstruction Devices for Arthrodesis •Joint Reconstruction Devices for Other Technologies

Joint Reconstruction Devices Market by Type: •Knee Joint Reconstruction Devices •Hip Joint Reconstruction Devices •Shoulder Joint Reconstruction Devices •Ankle Joint Reconstruction Devices •Other Joint Reconstruction Devices

Joint Reconstruction Devices Market by Region: •North America Joint Reconstruction Devices Market •Latin America Joint Reconstruction Devices Market •Europe Joint Reconstruction Devices Market •Asia Pacific Joint Reconstruction Devices Market •Middle East & Africa Joint Reconstruction Devices Market

[aegislifescience]

Revolutionizing Total Knee Arthroplasty: The Role of ORC in Bleeding Control

Effective bleeding control remains a formidable challenge in modern surgery, particularly in orthopedic procedures where managing bleeding from the exposed or cut surface of cancellous bone is a critical concern. Total knee arthroplasty (TKA), a prevalent surgery for severe knee arthritis within orthopedics, is notably associated with significant blood loss due to extensive bone cutting and exposure of a large surface area of cancellous bone [1].

Challenges in TKA:

Patients undergoing primary TKA are particularly susceptible to significant intraoperative and postoperative blood loss, leading to potential complications such as pain, decreased range of motion, and delayed recovery. With an aging population and increased life expectancy, the annual incidence of TKA procedures is expected to rise, reaching an estimated 3 million in the United States by 2030 [2].

Role of Absorbable Haemostatic Agents:

To address bleeding challenges in orthopedic surgeries, particularly in TKA, absorbable haemostatic agents like oxidized regenerated cellulose (ORC) play a pivotal role. ORC, such as Surgicel Fibrillar™, assists in controlling capillary, venous, and small arterial haemorrhage when conventional methods like ligation or electrocoagulation are impractical or ineffective.

Understanding Oxidised regenerated cellulose (ORC)

Oxidized cellulose (OC) was initially employed as a haemostatic agent in 1942, and by 1960, oxidized regenerated cellulose (ORC) was developed[3]. Derived from plant-based cellulose, ORC undergoes oxidation and regeneration, resulting in a biocompatible and bioabsorbable material widely used in medical applications, with haemostasis being a primary focus. ORC facilitates haemostasis likely through the activation of the intrinsic coagulation pathway and also creating a gel-like layer (matrix) that holds clot in place and triggers vasoconstriction by the low pH of the ORC.

Commercially Available ORC Products:

Several commercially available hemostatic materials based on oxidized cellulose are currently in the market including Surgicel, Oxycel, Pahacel, CuraCel, Surgi-ORC® (Aegis Lifesciences Pvt. Ltd.) [3].

Different variants of Surgi-ORC® from Aegis Lifesciences:

Surgi-ORC® Original, Surgi-ORC® Knit, Surgi-ORC® Fibril and Surgi-ORC® Non-woven haemostats are white or pale yellow in color and can be cut into desired sizes for different surgeries.Surgi-ORC® Absorbable haemostats are fully absorbed with minimum tissue reaction.

Clinical study on ORC in total knee arthroplasty (TKA):

A recent clinical study conducted by Li et al. in 2023 investigated the local treatment of 70 TKA patients with oxidized regenerated cellulose (ORC), specifically SurgicelFibrillar™(2.5 * 5.1 cm; Ethicon Inc., San Lorenzo, Puerto Rico, USA). The study demonstrated a significant decrease in overall blood loss among TKA patients treated with regenerated oxidized cellulose (ORC) compared to those in the suture-based group. This underscores the safe and effective application of ORC in reducing postoperative blood loss in Total Knee Arthroplasty.

Conclusion:

As advancements in haemostatic agents continue to reshape the landscape of orthopedic surgeries, ORC emerges as a promising solution in TKA, offering surgeons an effective tool to address bleeding challenges and improve patient outcomes. The future of orthopedic surgery, particularly in TKA, holds exciting possibilities with the continued exploration and utilization of innovative haemostatic technologies. 

References:

Kim JK, Ro DH, Han SM, Lee MC, Han HS. Efficacy and Safety of Bioabsorbable Bone Hemostatic Agent in Total Knee Arthroplasty: A Prospective Randomized Controlled Trial. Clinical and Applied Thrombosis/Hemostasis. 2021; 27:1-6.

Helito CP, Bonadio MB, Sobrado MF, Giglio PN, Pécora JR, Camanho GL, Demange MK. Comparison of floseal® and tranexamic acid for bleeding control after total knee arthroplasty: a prospective randomized study. Clinics. 2019; 74:

Rodić-Grabovac B, Sailović P, Lipić N. Medical and pharmaceutical application of oxidized cellulose. Journal of Chemists, Technologists and Environmentalists. 2020;1(1):1-11.

Li B, Pan W, Sun X, Qin K, Bai G, Bao H, Huang Y, Ma J. Hemostatic effect and safety evaluation of oxidized regenerated cellulose in total knee arthroplasty-a randomized controlled trial. BMC Musculoskeletal Disorders. 2023;24(1):797.

[techninja]

Partial Knee Arthroplasty Market Trends: Shaping the Future of Knee Surgery

Introduction

The Partial Knee Arthroplasty (PKA) market has witnessed substantial growth and innovation in recent years, driven by an aging population, increasing cases of osteoarthritis, and advancements in medical technology. This minimally invasive surgical procedure offers a less invasive option for patients suffering from isolated knee joint damage, allowing them to retain more natural knee function. This article explores the current state of the Partial Knee Arthroplasty market, its growth prospects, and the key factors contributing to its expansion.

Market Overview

Partial Knee Arthroplasty, also known as unicompartmental knee arthroplasty, is a surgical procedure that involves the replacement of only a portion of the knee joint, as opposed to total knee replacement. It is primarily used to treat osteoarthritis patients whose joint damage is limited to a single compartment of the knee. This minimally invasive technique has garnered attention due to its reduced recovery time and the preservation of healthy knee tissue.

Growth Drivers

1. Aging Population: The global demographic shift towards an older population is a significant driver for the PKA market. As people age, the risk of developing osteoarthritis, a common condition that often requires knee surgery, increases. Partial Knee Arthroplasty offers a solution that allows patients to maintain their quality of life while addressing knee joint issues.

2. Technological Advancements: The development of more precise and durable implants, along with improved surgical techniques, has significantly enhanced the outcomes of PKA procedures. Patients now experience less pain, shorter hospital stays, and faster recovery times. The use of robotics and computer-assisted surgery has also improved the precision of PKA procedures.

3. Cost-Effective Solution: Compared to total knee replacement, partial knee arthroplasty is often a more cost-effective solution for healthcare systems and patients. It involves fewer hospital resources and offers quicker rehabilitation, reducing the overall healthcare burden.

4. Patient Satisfaction: Many patients report higher satisfaction rates with PKA compared to total knee replacement, as it allows them to maintain a more natural feeling and range of motion in their knees. This positive patient experience is driving demand for the procedure.

Market Challenges

1. Limited Patient Eligibility: Not all patients with knee osteoarthritis are suitable candidates for PKA. Only individuals with localized joint damage are eligible, which restricts the potential patient pool.

2. Awareness and Education: Many patients and healthcare providers are not fully aware of the benefits and eligibility criteria for PKA. Raising awareness and educating medical professionals is a crucial aspect of expanding the market.

Market Trends

1. Outpatient Procedures: A growing trend in the PKA market is the shift towards performing procedures in an outpatient setting. This reduces the cost and the inconvenience associated with hospital stays and can contribute to market growth.

2. Custom Implants: The use of custom-designed implants, tailored to the patient's specific knee anatomy, is gaining popularity. This leads to improved fit and function, further enhancing patient outcomes.

3. Global Expansion: The PKA market is not limited to developed countries. Emerging economies are also witnessing growth in PKA procedures due to increased healthcare access and awareness.

Conclusion

The Partial Knee Arthroplasty market is poised for continued growth as it addresses the healthcare needs of an aging population and leverages technological advancements in the field. While challenges exist, including limited patient eligibility and the need for greater awareness, the market's trajectory remains positive. As the industry continues to evolve, it is essential for healthcare professionals and manufacturers to collaborate to improve patient outcomes and expand access to this valuable surgical option for those suffering from knee osteoarthritis.

[vanshika393]

Cementless Total Knee Arthroplasty Market- Future Growth Prospects for the Global Leaders

The latest market report published by Credence Research, Inc. “Global Cementless Total Knee Arthroplasty Market: Growth, Future Prospects, and Competitive Analysis, 2016 – 2028. The global Cementless Total Knee Arthroplasty Market has been steadily growing in recent years and is predicted to increase at a CAGR of 5.20% between 2023 and 2030. The market was valued at USD 1948.9 million in 2022 and is predicted to reach USD 2923.5 million in 2030.

Cementless Total Knee Arthroplasty (TKA) Market" refers to the market for orthopedic surgical procedures and implant devices used in total knee replacement surgery without the use of bone cement. Total Knee Arthroplasty, commonly known as knee replacement surgery, is a surgical procedure performed to replace a damaged or worn-out knee joint with a prosthetic implant to relieve pain and improve joint function.

Cementless TKA involves using implant components that are designed to promote bone ingrowth and long-term stability without the need for cement. These components often have a porous surface that allows the patient's own bone to grow into the implant, creating a strong bond over time. The primary advantage of cementless TKA is the potential for improved long-term fixation and reduced risk of cement-related complications.

The "Cementless Total Knee Arthroplasty Market" encompasses the various companies, products, and services related to cementless knee replacement procedures and implants. This market may include orthopedic device manufacturers, healthcare providers, surgeons, and other stakeholders involved in the development, distribution, and utilization of cementless TKA implants and related technologies.

Here are some of the key challenges and risks in the cementless TKA market:

Technical Complexity: Cementless TKA is technically more challenging than traditional cemented TKA. Proper alignment and fixation of the components are critical for long-term success, and surgeons need to have a high level of skill and experience to perform the procedure effectively.

Patient Selection: Not all patients are suitable candidates for cementless TKA. Factors such as bone quality, patient age, and activity level must be carefully considered when selecting patients for this procedure. Inappropriate patient selection can lead to poorer outcomes.

Implant Integration: Achieving stable implant integration with the patient's bone can be more challenging in cementless TKA. If the components do not osseointegrate properly, it can lead to implant loosening, instability, and the need for revision surgery.

Implant Wear and Debris: Like all joint replacements, cementless TKAs can generate wear particles over time. These wear particles can lead to inflammation, bone loss, and implant failure if not managed properly. Surgeons and patients must be aware of the potential for long-term complications.

Some of the major players in the market and their market share are as follows:

Zimmer Biomet

Smith & Nephew plc

Stryker Corporation

Group FH Ortho

DePuy Synthes

Johnson & Johnson

Corin Group plc

B. Braun Melsungen AG

Waldemar Link GmbH and Co. KG

Browse 249 pages report Cementless Total Knee Arthroplasty Market By Implant Type (Fixed-Bearing Implants, Mobile-Bearing Implants) By Material (Cobalt-Chromium Alloys, Titanium Alloys, Polyethylene Other Biomaterials) By Fixation Type (Press-Fit Implants, Bone Ingrowth Implants) By Surgical Approach (Medial Parapatellar Approach Subvastus Approach Lateral Parapatellar Approach)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030 - https://www.credenceresearch.com/report/cementless-total-knee-arthroplasty-market

Here are some of the key growth factors influencing the market:

Aging Population: The global population is aging, with an increasing number of elderly individuals suffering from knee joint problems and osteoarthritis. This demographic trend is a major driver of the TKA market as older individuals often require knee replacement surgery to improve their quality of life.

Technological Advancements: Advances in medical technology, including improvements in materials, implant designs, and surgical techniques, have made cementless TKA procedures more effective and durable. These innovations have led to higher patient satisfaction rates and increased demand for cementless implants.

Patient Preference: Many patients prefer cementless TKA over traditional cemented implants because they can potentially provide better long-term results and reduce the risk of implant loosening. Patients are becoming more informed about their options and are often willing to pay for advanced, cementless solutions.

Surgeon Training and Experience: Surgeons are becoming more proficient in performing cementless TKA procedures, leading to better outcomes. The increasing expertise of surgeons in this area contributes to the growth of the market.

Key Segments

By Implant Type

Fixed-Bearing Implants

Mobile-Bearing Implants

By Material

Cobalt-Chromium Alloys

Titanium Alloys

Polyethylene

Other Biomaterials

By Fixation Type

Press-Fit Implants

Bone Ingrowth Implants

Why to Buy This Report-

The report provides a qualitative as well as quantitative analysis of the global Cementless Total Knee Arthroplasty Market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, the base year- 2021, and the projection period 2022-2028.

The report includes information on the competitive landscape, such as how the market's top competitors operate at the global, regional, and country levels.

Major nations in each region with their import/export statistics

The global Cementless Total Knee Arthroplasty Market report also includes the analysis of the market at a global, regional, and country-level along with key market trends, major players analysis, market growth strategies, and key application areas.

Browse Complete Report- https://www.credenceresearch.com/report/cementless-total-knee-arthroplasty-market

Visit our Website- https://www.credenceresearch.com/

Related Reports- https://www.credenceresearch.com/report/dermatology-endoscopy-devices-market

https://www.credenceresearch.com/report/cell-and-gene-therapy-clinical-trials-market

Browse Our Blog- https://www.linkedin.com/pulse/cementless-total-knee-arthroplasty-market-size-worth-usd-shukla

About Us -

Credence Research is a viable intelligence and market research platform that provides quantitative B2B research to more than 10,000 clients worldwide and is built on the Give principle. The company is a market research and consulting firm serving governments, non-legislative associations, non-profit organizations, and various organizations worldwide. We help our clients improve their execution in a lasting way and understand their most imperative objectives. For nearly a century, we’ve built a company well-prepared for this task.

Contact Us:

Office No 3 Second Floor, Abhilasha Bhawan, Pinto Park, Gwalior [M.P] 474005 India

[rahulcmi]

Global Surgical Robots Market Is Estimated To Witness High Growth Owing To Increasing Adoption of Minimally Invasive Surgeries and Technological Advancements

The global Surgical Robots Market is estimated to be valued at US$ 5,721.6 million in 2022 and is expected to exhibit a CAGR of 13.4% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights.

A) Market Overview:

The Surgical Robots Market involves the use of robotic systems in performing surgical procedures. These robotic systems assist surgeons in performing intricate surgeries with enhanced precision, control, and flexibility. Surgical robots offer various benefits such as reduced trauma to patients, smaller incisions, faster recovery time, and improved surgical outcomes. The use cases of surgical robots include procedures such as gynecological surgeries, urological surgeries, cardiothoracic surgeries, orthopedic surgeries, and general surgeries.

B) Market Dynamics:

The market dynamics of the Surgical Robots Market are driven by two main factors: increasing adoption of minimally invasive surgeries and technological advancements.

1. Driver: Increasing Adoption of Minimally Invasive Surgeries

Minimally invasive surgeries have gained popularity in recent years due to their advantages over traditional open surgeries. These procedures involve smaller incisions, reduced blood loss, shorter hospital stays, and faster recovery time for patients. Surgical robots enable surgeons to perform complex procedures with greater precision and accuracy, further promoting the adoption of minimally invasive surgeries.

For example, the da Vinci Surgical System by Intuitive Surgical is a widely used surgical robot that offers enhanced visualization, dexterity, and precision. It allows surgeons to perform complex procedures through small incisions, resulting in less pain, reduced scarring, and faster recovery for patients.

2. Opportunity: Technological Advancements

Technological advancements are driving the growth of the Surgical Robots Market. The development of advanced robotic systems with improved imaging capabilities, real-time feedback, and artificial intelligence integration is revolutionizing the field of surgery. Robots equipped with haptic technology provide surgeons with a realistic sense of touch, enhancing their surgical skills.

For instance, Think Surgical's TSolution One Surgical System utilizes advanced imaging and planning software to enable surgeons to perform total knee arthroplasty with precision and accuracy. This system offers real-time feedback during the surgery, enabling adjustments as needed for optimal outcomes.

C) Segment Analysis:

The Surgical Robots Market can be segmented based on product type, application, and end-user. In terms of product type, the market can be divided into systems and instruments & accessories. The systems segment is expected to dominate the market due to the high cost associated with surgical robots. Based on application, the market can be categorized into gynecological surgeries, urological surgeries, cardiothoracic surgeries, orthopedic surgeries, and general surgeries. Among these, urological surgeries are expected to dominate the market as robotic systems offer precise control and better outcomes in complex urological procedures. In terms of end-user, the market can be segmented into hospitals and ambulatory surgical centers.

D) PEST Analysis:

Political: Governments play a crucial role in regulating the use of surgical robots and ensuring patient safety.

Economic: The rising healthcare expenditure and the growing demand for advanced surgical procedures are driving market growth.

Social: Increasing awareness among the general population regarding the benefits of minimally invasive surgeries is contributing to market growth.

Technological: Technological advancements in robotic systems, such as 3D imaging, artificial intelligence, and haptic technology, are shaping the future of surgical robots.

E) Key Takeaways:

The global Surgical Robots Market is expected to witness high growth, exhibiting a CAGR of 13.4% over the forecast period, due to increasing adoption of minimally invasive surgeries and technological advancements.

North America is expected to be the fastest-growing and dominating region in the market due to the presence of key market players, favorable reimbursement policies, and the high adoption rate of surgical robots.

Key players operating in the global Surgical Robots Market include Intuitive Surgical, Think Surgical, Asensus Surgical US, Inc., Zimmer Biomet, Stryker, Smith & Nephew, Novus Health Products, and Medtronic.

[healthcaremarketfmi]

Surgical Tourniquets Market Share, Top Operating Players, Recent Enhancements and Regional Analysis 2029

FMI’ analysis expects the surgical tourniquets market to grow at ~8% CAGR through to 2029, driven a surge in the number of trauma cases over the years lined with rising demand for effective device to stop arterial bleeding during surgical procedures. Analysts also expect that automatic machines and robotic technologies are likely to bring a paradigm shift in operative procedures, which should push the manufacturers to innovate their products and develop strategies to attract and retain a new segment of customers.

Worldwide sales of surgical tourniquets will increase by 7.5% year-over-year to reach ~US$ 381 million in 2019, up from ~US$ 355 million in 2018, according to the latest research from Future Market Insights (FMI).

Surgical tourniquets have long been reliable to establish a bloodless field of operation for surgeons while maintaining a high level of safety for patients. However, the risk of surgical-site infections as well as tourniquet-related injuries, particularly due to the application of high pressures and high pressure gradients to the patient, remains a potential threat to the market growth.

In an attempt to reduce the risks associated with higher tourniquet pressures, manufacturers are placing their bets on products innovations and introduction of novel features such as automatic pressure control, audiovisual alarms, digital displays, and easy-to-use user interface.

For More Information : https://www.futuremarketinsights.com/reports/surgical-tourniquets-market

Sales of Tourniquet Cuffs to Ramp up in 2019

According to the FMI analysts, tourniquet cuffs have been a vital part of the modern computer-assisted tourniquet system, which accounted for ~77% of total market revenue in 2018. While the inflatable disposable cuffs represented more than half of the total tourniquet cuff sales in 2018, the consumption of inflatable reusable cuffs is likely to increase 7.6% y-o-y in 2019.

“In terms of tourniquet systems, dual channel systems will continue to represent a relatively high share as compared to single channel systems, in the view of enabling bi-lateral procedures or simultaneous surgeries of both upper and lower extremity,” the FMI analyst said.

The consumption of surgical tourniquets for knee arthroplasty accounted for ~31% sales in 2018, while increasing application in amputation of limbs and trauma cases is likely to result in increased market share in the future.

“Recent advancements in reverse shoulder arthroplasty along with the introduction of ‘personalized’ tourniquet systems that allow the use of variable contour design and cuffs for specific patients will open new avenues of growth for the market players,” said the FMI analyst.

Hospitals Capture Significant Share, North America in the Vanguard

In 2018, surgical tourniquets worth ~US$ 176 million were sold in hospitals; according to the FMI analysts, growing number of hospitals, especially in developing countries, and greater awareness of advanced medical devices will continue to drive the consumption of surgical tourniquets in hospitals.

Rapid adoption of ‘value-based’ model in health care settings have led to a surge in the number of ambulatory surgical centers and specialized clinics, thereby paving a new way of growth for the surgical tourniquets market.

The FMI analyst forecasts that North America will continue to remain at the forefront of surgical tourniquets market, representing 30% share in 2018. While North America is likely to be neck-and-neck with Europe to lead the market in future, manufacturers are tapping into new opportunities in developing countries in Asia Pacific.

The surgical tourniquets market shows a fair level of fragmentation, with two prominent players including Zimmer Biomet and Stryker Corporation accounting for more than one-third of the total revenue share. Exploring unmet needs in developing regions and expanding their distribution through collaboration and acquisitions of local and regional manufacturers remain key focal points of the market players.

Key Segment

By Product Type

Tourniquet Systems

Single Channel Systems

Dual Channel Systems

Tourniquet Cuffs

Inflatable Cuffs

Disposable Cuffs

Reusable Cuffs

Non-Inflatable Cuffs

Disposable Cuffs

Reusable Cuffs

[impossibledeanmakerwombat]

Optical Technology Enabled Orthopedic Navigation Systems Market Trends | Segmentation, Outlook, Industry Report to 2032

The Orthopedic Navigation Systems Market revenues were estimated at US$ 2.4 Billion in 2022 and is anticipated to grow at a CAGR of 16.9% from 2023 to 2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 10.4 Billion.

Increasing financing initiatives from the government for surgical navigation system research and development is also contributing to market growth. The high cost of surgical navigation systems and product recalls, on the other hand, are anticipated to have a negative impact on the orthopedic navigation systems market’s growth.

Businesses are concentrating on raising knowledge about the use and benefits of orthopedic navigation systems among healthcare professionals and patients. In developed countries, manufacturers of surgical navigation systems have begun to reach out to local communities by offering CME classes. As a result, physicians and experts are becoming more aware of the availability and use of orthopedic navigation systems.

𝑮𝒆𝒕 𝑳𝒂𝒕𝒆𝒔𝒕 𝑺𝒂𝒎𝒑𝒍𝒆 𝑪𝒐𝒑𝒚@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16600

Furthermore, commercially marketed orthopedic navigation systems come with a six to seven-year warranty, resulting in a seven-year product sales cycle. Due to the increased demand for technology aid in orthopedic treatments, the market for orthopedic navigation systems is likely to expand throughout the forecast period.

Competitive Landscape

The key players operating in Orthopedic Navigation Systems Market include Stryker, Medtronic, Johnson & Johnson Services, B. Braun Melsungen AG, Smith + Nephew, OrthAlign, Globus Medical, and Zimmer Biomet.

In February 2021, Brainlab, received FDA clearance for both Cirq and Loop-X Mobile Imaging Robot. Following the CE mark approval, the FDA’s clearance paved the way for Brainlab to enter the U.S. market with the Cirq robotic alignment module for spine procedures, and Loop-X, a fully robotic intraoperative imaging device on the market.

𝑨𝒔𝒌 𝑨𝒏 𝑨𝒏𝒂𝒍𝒚𝒔𝒕@ https://www.futuremarketinsights.com/ask-question/rep-gb-16600

In January 2021, DePuy Synthes received 510(k) FDA clearance for VELYS robotic-assisted solution. It is designed for use with the ATTUNE total knee system.

In November 2020, Stryker, completed the acquisition of Wright Medical, in an attempt to enhance its market position globally in trauma and extremities. It will provide the company with significant opportunities to improve outcomes, advance innovation, and increase patient reach.

In July 2020, Smith + Nephew, publicized the introduction of the RI.HIP Navigation for Total Hip Arthroplasty (THA). This device received 510(k) clearance from the U.S. FDA and CE Mark certification for THA.

More Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the Orthopedic Navigation Systems Market by Application ( Knee, Hip, Spine), by Technology (Electromagnetic, Optical, Other Technologies), by End Use (Hospitals, Ambulatory Surgery Centers), and by Region, presenting historical market data (2018-2022) and forecast statistics for the period of 2023-2033.

Market Segments Covered in Orthopedic Navigation Systems Market Analysis

By Application:

Knee

Hip

Spine

𝑩𝒖𝒚 𝑵𝒐𝒘/𝑷𝒖𝒓𝒄𝒉𝒂𝒔𝒆@ https://www.futuremarketinsights.com/checkout/16600

By Technology:

Electromagnetic

Optical

Other Technologies

By End Use:

Hospitals

Ambulatory Surgery Centers

[jenniferthomson123]

Boom In Knee Replacement Market By 2030: Grab The Business Opportunity

The global knee replacement market is predicted to reach a valuation of US$ 9.4 billion in 2022, with a projected compound annual growth rate (CAGR) of 4.1% during the forecast period from 2023 to 2030. Knee replacement also referred to as knee arthroplasty or total knee replacement, is a surgical procedure that aims to repair a knee damaged by arthritis. Some major companies in the Knee Replacement Market include Zimmer Biomet, Stryker Corporation, Smith & Nephew Plc, Johnson & Johnson Services Inc., B. Braun Melsungen AG, Medacta International, MicroPort Scientific Corporation, ConforMIS, Inc., Corin Group, Exactech, Inc., DJO Global, Inc., Baumer Holding AG, SurgTech Inc., Wright Medical Group N.V., and X.NOV.